FDA Approves Additive Orthopaedics’ Patient Specific Talus Spacer

Additive Orthopaedics Patient Specific Talus Spacer

Additive Orthopaedics received an approval order from FDA for its Humanitarian Device Exemption (HDE) application for the Patient Specific Talus Spacer for treatment of avascular necrosis of the talus. This is the first patient specific total talus replacement implant approved by FDA.

Under the HDE, the Patient Specific Talus Spacer will...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0